Search filters

Filters
Clear All

Phase

  • 7
  • 5
  • 9
  • 1
  • 4
  • 7
  • 33
  • 4
  • 1
  • 3
  • 29

Found 33 Adenocarcinoma trials

A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
UPCC 17925/28925 Molecular Residual Disease in Solid Tumors: A Prospective Study to Collect Clinical Data and Biospecimens to Support Discovery and Development of Cancer Biomarkers
18 years or above
All genders
Observational
This study investigates solid tumors. Participants will provide clinical data and biological samples to support cancer biomarker research.The focus of this study is to evaluate the development of tests for cancer detection and assessing the risk of cancer recurrence.Who can participate: Adults aged 18 and older with a confirmed diagnosis …
18 years - 89 years
All genders
Interventional
This study investigates the best way to treat patients with Barrett's esophagus and low-grade dysplasia by comparing two procedures: endoscopic surveillance and endoscopic eradication therapy. Low-grade dysplasia is an early form of abnormal cell growth that may not always progress to cancer. Endoscopic surveillance involves using a camera-equipped tube to …
18 years or above
All genders
Phase 2
Interventional
This study investigates the combination of an investigational medication, administered as telomelysin (OBP-301), with pembrolizumab in patients with advanced or metastatic gastric or gastroesophageal junction cancer. The purpose of this study is to determine if this combination is safe and effective for patients whose cancer has progressed despite previous treatments.Participants …
18 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effectiveness of adding RP2, an investigational treatment, to the standard chemotherapy regimen, FLOT, for patients with stage II or higher, non-metastatic gastroesophageal adenocarcinoma. The purpose of this study is to determine if injecting RP2 directly into the tumors of the stomach and esophagus, combined …
UPCC 22921 An Open-Label, Multicenter, First-in-Human, Dose-Escalation Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
12 years - 85 years
All genders
Phase 1
Interventional
This study investigates the effects of an investigational medication targeting advanced or metastatic solid tumors, including sarcomas. The purpose of this research is to understand how the investigational medication, a recombinant humanized tetravalent antibody, interacts with the human death receptor 5 (DR5). The study aims to explore its potential therapeutic …
99 years or below
All genders
To establish novel cell lines from patients with and without Barretts with GERD so we can provide data to support grant proposals to be submitted for NIH funding. N/A N/A
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and effectiveness of an investigational oral medication designed to degrade SMARCA2 in patients with advanced or metastatic solid tumors that have a SMARCA4 mutation. The purpose of this study is to understand how the investigational medication affects the body, how it is processed by the …
18 years - 130 years
All genders
Observational
The purpose of this study is to investigate the effectiveness of an investigational medication in patients with HER2-positive solid tumors that are locally advanced, unresectable, or metastatic. In this study, HER2-positive is identified as IHC 3+. The study focuses on patients who have previously received systemic treatment for their condition …
18 years or above
All genders
Phase 2
Interventional
This study investigates a maintenance immunotherapy using CD40/Dectin-1 for patients with unresectable pancreatic ductal adenocarcinoma (PDA) who have not shown disease progression after 4-6 months of first-line chemotherapy. This research aims to explore the effectiveness of an investigational immunotherapy in maintaining disease stability in these patients.The study involves several procedures, …
18 years or above
All genders
Phase 2
Interventional
This study investigates the effects of combining an investigational medication with another treatment for patients with metastatic colorectal cancer that primarily affects the liver. In this study, researchers are looking at how the combination treatment works and its safety for patients.Participants in the study will receive the investigational medication along …
1 - 10 of 33